Correlation Between Autolus Therapeutics and Solid Biosciences

Can any of the company-specific risk be diversified away by investing in both Autolus Therapeutics and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Autolus Therapeutics and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Autolus Therapeutics and Solid Biosciences LLC, you can compare the effects of market volatilities on Autolus Therapeutics and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Autolus Therapeutics with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Autolus Therapeutics and Solid Biosciences.

Diversification Opportunities for Autolus Therapeutics and Solid Biosciences

0.62

Correlation Coefficient

Autolus Therapeutics  Solid Biosciences

Poor diversification

The 3 months correlation between Autolus and Solid is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Autolus Therapeutics and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Autolus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Autolus Therapeutics are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Autolus Therapeutics i.e., Autolus Therapeutics and Solid Biosciences go up and down completely randomly.

Pair Corralation between Autolus Therapeutics and Solid Biosciences

Given the investment horizon of 90 days Autolus Therapeutics is expected to under-perform the Solid Biosciences. In addition to that, Autolus Therapeutics is 1.01 times more volatile than Solid Biosciences LLC. It trades about -0.15 of its total potential returns per unit of risk. Solid Biosciences LLC is currently generating about -0.09 per unit of volatility. If you would invest  608.00  in Solid Biosciences LLC on August 11, 2025 and sell it today you would lose (202.00) from holding Solid Biosciences LLC or give up 33.22% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Autolus Therapeutics  vs.  Solid Biosciences LLC

Autolus Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Autolus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Solid Biosciences LLC

Risk-Adjusted Performance

Weakest

Over the last 90 days Solid Biosciences LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Autolus Therapeutics and Solid Biosciences

The main advantage of trading using opposite Autolus Therapeutics and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Autolus Therapeutics position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.

The idea behind Autolus Therapeutics and Solid Biosciences LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.